期刊文献+

17-AAG联合顺铂对人肝癌HepG2细胞增殖和凋亡的影响 被引量:2

Effects of 17-AAG combined with cisplatin on proliferation and apoptosis of human hepatoma cell line HepG2
下载PDF
导出
摘要 目的观察热休克蛋白90抑制剂17-AAG联合顺铂(DDP)对人肝癌Hep G2细胞增殖的影响,并探讨其机制。方法将对数生长期的Hep G2细胞分为对照组和A、B、C组。对照组只加培养基。A组加入0.625μmol/L的17-AAG,B组加入1.0μg/m L的DDP,C组加入0.625μmol/L的17-AAG和1.0μg/m L的DDP。培养24、48 h后用MTT法测算A、B、C组细胞增殖抑制率,用流式细胞术测算各组细胞凋亡率,用RT-PCR法检测各组Bax、Bcl-2mRNA。结果 A、B、C组培养48 h时细胞增殖抑制率均高于培养24 h时,P均<0.05;培养时间相同时C组细胞增殖抑制率高于A、B组,P均<0.05。培养48 h后A、B、C组细胞凋亡率和Bax mRNA均高于对照组,Bcl-2 mRNA低于对照组,P均<0.05;C组细胞凋亡率和Bax mRNA均高于A、B组,Bcl-2 mRNA低于A、B组,P均<0.05。结论17-AAG对人肝癌Hep G2细胞具有生长抑制作用,其与顺铂联合有协同作用。其机制可能与上调细胞Bax mRNA、下调Bcl-2 mRNA表达有关。 Objective To explore the effects of 17-AAG combined with cisplatin( DDP) on the proliferation of human hepatocellular carcinoma Hep G2 cells and its mechanism. Methods Hep G2 cells in the logarithmic phase were divided into the control group and groups A,B and C. The control group was only added with medium. Group A was added with0. 625 μmol / L 17-AAG,group B was added with 1. 0 μg / m L DDP,and group C was added with 0. 625 μg / m L 17-AAG and 1. 0 μg / m L DDP. After being cultured for 24 h and 48 h,the cell proliferation inhibition rates of groups A,B and C were determined by MTT,the apoptosis rate was measured by flow cytometry,and the Bax and Bcl-2 mRNA in each group was measured by RT-PCR. Results The cell proliferation inhibition rates of groups A,B and C which were cultured for 48 h were all higher than those of being cultured for 24 h( all P〈0. 05),the cell proliferation inhibition rate of group C was higher than those of groups A and B at the same time of culture( all P〈0. 05). After being cultured for 48 h,the apoptosis rate and Bax mRNA in the groups A,B and C were higher than that of the control group,while Bcl-2 mRNA was lower than that of the control group( all P〈0. 05); the apoptosis rate and Bax mRNA of group C were higher than those of groups A and B,but the Bcl-2 mRNA was lower than those of groups A and B( all P〈0. 05). Conclusions 17-AAG inhibits the growth of human hepatocellular carcinoma Hep G2 cells and has synergistic effect with cisplatin. The mechanism may be related to the up-regulation of Bax mRNA and down-regulation of Bcl-2 mRNA expression.
出处 《山东医药》 CAS 北大核心 2015年第38期7-9,共3页 Shandong Medical Journal
基金 陕西省高水平大学建设专项资金资助项目(2013SXTS02) 延安市科学技术研究发展计划项目(2013-KW15) 延安市肿瘤防治重点实验室资助项目(2014-78)
关键词 17丙烯胺-17-去甲氧格尔结霉素 热休克蛋白抑制剂 顺铂 肝细胞癌 细胞增殖 细胞凋亡 BAX蛋白 Bcl-2蛋白 17-AAG heat-shock proteins inhibitor cisplatin hepatocellular carcinoma cell proliferation apoptosis Bax protein Bcl-2 protein
  • 相关文献

参考文献15

  • 1张思维,郑荣寿,曾红梅,陈万青.1989-2008年中国肝癌发病性别、地区及年龄变化分析[J].中华预防医学杂志,2014,48(5):355-360. 被引量:38
  • 2Badowska-Kozakiewicz AM,Malicka E.Immunohistochemical evaluation of expression of heat shock proteins HSP70 and HSP90 in mammary gland neoplasms in bitches[J].Polish J Veter Sci,2012,15(2):209-214.
  • 3连莉莎,苟冬梅,吴永梅.热休克蛋白与常见消化道肿瘤相关性的研究进展[J].山东医药,2012,52(39):89-91. 被引量:4
  • 4Soroka J,Wandinger SK,Musbacher N,et al.Conformational Switching of the Molecular Chaperone Hsp90 via Regulated Phosphorylation[J].Molecular Cell,2012,45(4):517-528.
  • 5Whitesell L,Lindquist SL.HSP90 and the chaperoning of cancer[J].Nat Rev Cancer,2005,5(10):76l-772.
  • 6Kabakow AE,Makarova YM,Malyutina YV.Radiosensitization of Human Vascular Endothelial Cells Throulgh Hsp90 Inhibition With17-N-Allilamino-17-Demethoxygeldanamycin[J].Int J Radiat Oncol Bio Phys,2008,71(3):858-865.
  • 7Wang X,Ju W,Renouard J,et al.17-Allylamino-17-Demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kb pathway[J].Cancer Res,2006,66(2):1089-1095.
  • 8鲍嫘,赵恩锋,周桂霞,石怀银.热休克蛋白与宫颈癌放射敏感性的相关性[J].山东医药,2014,54(17):51-53. 被引量:1
  • 9Hanson BE,Vesole DH.Retaspimycin hydrochloride(IPI-504):a novel heat shock protein inhibitor as an anticancer agent[J].Exp Opin Investi Drugs,2009,18(9):1375-1383.
  • 10赵学荣,王建平,肖丽君,许倩,赵恩宏,郑鑫,郑华川,赵爽.17-AAG阻滞HCT-15细胞周期并诱导其凋亡[J].中国病理生理杂志,2015,31(1):98-103. 被引量:4

二级参考文献66

共引文献52

同被引文献13

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部